PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

First European Framework Contracts for Influenza Pandemic Preparedness Awarded to Seqirus

Liverpool, UK – 8 April 2019 Seqirus, a global leader in influenza prevention, has announced that it has signed contracts with the European Commission and 15 Euro...
Continue Reading →
News

Pfizer uses real-world data to score Ibrance breast cancer nod in males

Pfizer's Ibrance is now approved for men with HR-positive, HER2-negative advanced or metastatic breast cancer. (Pfizer) Breast cancer is a rare disease in men, m...
Continue Reading →
News

FDA declares 40 generics free of carcinogens as ‘sartan’ recalls continue

The FDA said losartan pills with cancer-causing agents higher than the accepted limit would still be allowed to be temporarily distributed to prevent a nationwide s...
Continue Reading →
News

The top 15 pharma companies by 2018 revenue

Together, the top 15 drugmakers by 2018 revenue generated $560 billion in 2018. (Pixabay) The pharma industry is always in flux, but the big names always turn up...
Continue Reading →
News

AveXis expands world-leading gene therapy manufacturing capacity with purchase of advanced biologics therapy manufacturing campus in Longmont, Colorado

AveXis, a Novartis company, today announced it signed an agreement to purchase an advanced biologics therapy manufacturing campus in Longmont, Colorado, further expa...
Continue Reading →
News

Novartis adds clinical and preclinical anti-inflammatory programs to portfolio with acquisition of IFM Tre

Novartis announced that it is adding to its broad portfolio of immunomodulatory medicines with the planned acquisition of IFM Tre, a subsidiary of IFM Therapeutics L...
Continue Reading →
News

ACG Delighted to be Part of India State Visit to Croatia

Indian President, Ram Nath Kovind and the President of Croatia, Kolinda Grabar-Kitarovi? At the invitation of the President of Croatia, Kolinda Grabar-Kitarovi?, ...
Continue Reading →
News

German Merck finally gets yes for MS drug Mavenclad

The Food and Drug Administration has approved Merck KGaA's Mavenclad for the treatment of adults with relapsing-remitting multiple sclerosis (RRMS) and active second...
Continue Reading →
News

FDA approves treatment for patients with a type of inflammatory arthritis

The U.S. Food and Drug Administration today approved Cimzia (certolizumab pegol) injection for treatment of adults with a certain type of inflammatory arthritis call...
Continue Reading →
News

Did Novartis hand out kickbacks or host educational dinners? A jury may decide

A Novartis spokesman said the company "continue[s] to believe that the government has insufficient evidence to support its claims” that its doctor dinners served as...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026